MedTrace Logo

Hemostasis With QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access

NCT03535597 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 355

Last updated 2024-09-24

Study results available
· View outcomes & findings →

Summary

To evaluate the efficacy and safety of the QuikClot® Radial® pad on hemostasis after transradial access (TRA), compared to the standard of care TR Band®, to hopefully develop a safe and efficacious technique to achieve more rapid patent hemostasis after TRA, and improve patient care by optimizing radial hemostasis management.

Conditions

Interventions

DEVICE

Quikclot Radial (QC) Pad

The QC pad will be applied over the radial artery access site covered with either a Coban™ bandage, a Tegaderm™ dressing, or a TR Band after TRA.

Sponsors & Collaborators

  • Z-Medica

    collaborator INDUSTRY

  • Memorial Healthcare System

    lead OTHER

Principal Investigators

  • Jonathan Roberts, MD · Memorial Healthcare System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2022-12-28
Completion
2022-12-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03535597 on ClinicalTrials.gov